US Stock MarketDetailed Quotes
MBX MBX Biosciences
- 22.900
- +6.900+43.13%
Trading Sep 13 12:29 ET
690.52MMarket Cap-14632P/E (TTM)
23.300High22.000Low360.98KVolume23.000Open16.000Pre Close8.29MTurnover1.20%Turnover RatioLossP/E (Static)30.15MShares0.00052wk High-7.05P/B690.52MFloat Cap0.00052wk Low--Dividend TTM30.15MShs Float0.000Historical High--Div YieldTTM8.13%Amplitude0.000Historical Low22.966Avg Price1Lot Size
MBX Biosciences Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|
| Total revenue | 0 | 0 |
| Operating revenue | --0 | --0 |
| Cost of revenue | ||
| Gross profit | ||
| Operating expense | 40.34%35.31M | 25.16M |
| Selling and administrative expenses | 80.05%6.78M | --3.76M |
| -General and administrative expense | 80.05%6.78M | --3.76M |
| Research and development costs | 33.36%28.53M | --21.4M |
| Operating profit | -40.34%-35.31M | -25.16M |
| Net non-operating interest income expense | 137,500.00%2.75M | -2K |
| Non-operating interest income | 638.71%2.75M | --372K |
| Non-operating interest expense | --0 | --374K |
| Other net income (expense) | -972K | |
| Gain on sale of security | ---- | ---73K |
| Special income (charges) | --0 | ---899K |
| -Less:Other special charges | ---- | --899K |
| Income before tax | -24.60%-32.56M | -26.14M |
| Income tax | ||
| Net income | -24.60%-32.56M | -26.14M |
| Net income continuous Operations | -24.60%-32.56M | ---26.14M |
| Minority interest income | ||
| Net income attributable to the parent company | -24.60%-32.56M | -26.14M |
| Preferred stock dividends | ||
| Other preferred stock dividends | ||
| Net income attributable to common stockholders | -24.60%-32.56M | -26.14M |
| Basic earnings per share | -24.60%-1.0799 | -0.8667 |
| Diluted earnings per share | -24.60%-1.0799 | -0.8667 |
| Dividend per share | ||
| Currency Unit | USD | USD |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data